Digital health solutions company OptimizeRx (NASDAQ: OPRX) connects pharmaceutical companies, doctors, and patients via the thing doctors look at most: electronic health records. Could this approach eliminate the need for pharmaceutical sales representatives?
In this video from "Beat & Raise" on Motley Fool Live , recorded on Sept. 23 , tech, healthcare, and cannabis editor and analyst Olivia Zitkus provides a rundown of OptimizeRx's business, recent financials, and whether she believes the stock is worth buying now.
For further details see:
This Healthcare Tech Stock Wants to Cut Out the Middleman